rCAST评分有助于在ICU入院前评估儿童心脏骤停后综合征的神经预后:基于全国前瞻性登记数据库的外部验证研究
本研究为基于日本急诊医学会(JAAM)院外心脏骤停(OHCA)登记数据库的队列研究,纳入179例实现自主循环恢复的儿童心脏骤停后综合征(PCAS)患者,外部验证rCAST评分对30天和90天神经预后的预测准确性,并评估三个预设严重程度分类(低危≤5.5、中危6.0-14.0、高危≥14.5)下良好神经预后的概率。结果显示rCAST预测30天和90天神经预后的AUC分别为0.95(95%CI 0.90-0.99)和0.96(95%CI 0.91-1.00);30天良好神经预后比例在低危组为100%(12/12)、中危组为36.1%(13/36)、高危组为2.3%(3/131);评分超过17.0分的极高危组无良好神经预后患者。
要点
- 在179例儿童PCAS患者中,rCAST预测30天神经预后的AUC为0.95(95%CI 0.90-0.99),预测90天为0.96(95%CI 0.91-1.00)。
- rCAST低危组(≤5.5)30天良好神经预后比例为100%(12/12),中危组(6.0-14.0)为36.1%(13/36),高危组(≥14.5)为2.3%(3/131)。
- rCAST评分超过17.0分的极高危组患者中,无良好神经预后。
- 该评分可在ICU入院前用于儿童PCAS患者的神经预后分层评估。
- 研究为外部验证队列,数据来自日本全国前瞻性OHCA登记数据库。
适用人群与场景
- 纳入日本急诊医学会(JAAM)院外心脏骤停(OHCA)登记数据库中实现自主循环恢复的儿童PCAS患者,共179例进行分析。
- 研究场景为ICU入院前评估。
诊断标准与关键阈值
- 采用rCAST评分进行严重程度分类:低危≤5.5分,中危6.0-14.0分,高危≥14.5分;原文另提及超过17.0分为极高危组。
- rCAST评分为原文预先开发的成人PCAS预后评分,本研究将其应用于儿童PCAS患者。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型为基于全国前瞻性登记数据库的队列研究(外部验证),样本量为179例儿童PCAS患者,无多中心数信息。
- rCAST预测30天神经预后的AUC为0.95(95%CI 0.90-0.99),预测90天神经预后的AUC为0.96(95%CI 0.91-1.00)。
- 30天良好神经预后比例:低危组100%(12/12),中危组36.1%(13/36),高危组2.3%(3/131)。
- rCAST评分超过17.0分的极高危组无良好神经预后患者。
证据类型、等级与局限
- 证据类型为外部验证队列研究,基于日本全国前瞻性OHCA登记数据库。
- 局限:原文未明确提及;设计上为观察性登记研究,可能存在未测量混杂。
对床旁实践的改变
- 在ICU入院前,对儿童PCAS患者可使用rCAST评分进行神经预后分层:低危组(≤5.5)30天良好神经预后概率高(100%),高危组(≥14.5)概率低(2.3%),评分超过17.0分者无良好神经预后。
- 该评分有助于与家属沟通预后,但原文未提供基于评分的治疗决策推荐,不能据此单独决定停止治疗。
指南或共识出处
- 原文未提及指南或共识名称;研究数据来自日本急诊医学会(JAAM)院外心脏骤停(OHCA)登记数据库。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The objective of this cohort study was to investigate whether the revised post-Cardiac Arrest Syndrome for Therapeutic hypothermia score (rCAST), which we previously developed as a prognostic score for adult patients with post-cardiac arrest syndrome (PCAS), is also applicable to pediatric patients.
METHODS: Pediatric PCAS patients were included from an out-of-hospital cardiac arrest (OHCA) registry of the Japanese Association for Acute Medicine (JAAM). We validated the predictive accuracy of the rCAST for the neurological outcomes at 30 and 90 days. We also evaluated the probability of a good neurological outcome in each of the three specified severity categories based on the rCAST (low severity: ≤5.5; moderate severity: 6.0-14.0; high severity: ≥14.5).
RESULTS: Among the 737 pediatric patients with OHCA, the data of 179 pediatric PCAS patients in whom return of spontaneous circulation was achieved were analyzed. The areas under the curve (AUC) of the rCAST for predicting the neurological outcomes at 30 days and 90 days were 0.95 (95% CI: 0.90-0.99) and 0.96 (0.91-1.00), respectively. The proportions of patients with a good neurological outcome at 30 days were 100% (12/12) in the low severity group, 36.1% (13/36) in the moderate severity group, and 2.3% (3/131) in the high severity group.
CONCLUSIONS: The AUC of the rCAST for pediatric PCAS patients was found to be greater than 0.9 in the external validation, which corresponds to excellent predictive accuracy. There was no patient with good neurological outcome among the patients with more than 17.0 points (extremely high severity group).
参考来源
- Yasuda Y, Nishikimi M, Matsui K, et al. The rCAST score is useful for estimating the neurological prognosis in pediatric patients with post-cardiac arrest syndrome before ICU admission: External validation study using a nationwide prospective registry. Resuscitation. 2021. PMID: 34600971. doi:10.1016/j.resuscitation.2021.09.025
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。